Hipertensión arterial pulmonar tromboémbolica crónica

Mateo Porres-Aguilar; Javier Eduardo Anaya-Ayala; Mateo Porres-Muñoz; Francisco Bracamontes

2007, Número 2

<< Anterior Siguiente >>

Cir Cir 2007; 75 (2)

Hipertensión arterial pulmonar tromboémbolica crónica

Porres-Aguilar M, Anaya-Ayala JE, Porres-Muñoz M, Bracamontes F

Texto completo

Cómo citar este artículo

Artículos similares

Idioma: Español
Referencias bibliográficas: 45
Paginas: 123-130
Archivo PDF: 99.72 Kb.

RESUMEN

La hipertensión arterial pulmonar tromboembólica crónica se presenta en una minoría de pacientes que han sufrido un episodio tromboembólico agudo previo. Sin embargo, su incidencia ha venido en aumento, considerándose hoy en día como una entidad no tan poco frecuente. En los últimos años ha existido un gran avance en el conocimiento de la fisiopatolología, el abordaje diagnóstico, así como en las alternativas terapéuticas que pueden ser ofrecidas a los pacientes no candidatos a tromboendarterectomía pulmonar, tratamiento definitivo y curativo en este subtipo de hipertensión arterial pulmonar. Esta revisión se enfoca al abordaje diagnóstico y tratamiento farmacológico actual en pacientes no candidatos a cirugía.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Moser KM, Auger WR, Fedullo PF. Chronic major-vessel thromboembolic pulmonary hypertension. Circulation 1990;81:1735-1743.
2. Dalen JE, Alpert JS. Natural history of pulmonary embolism. Prog Cardiovasc Dis 1975;17:259-270.
3. Moser KM, Daily PO, Peterson KL, et al. Thromboendarterectomy for chronic, major-vessel thromboembolic pulmonary hypertension: immediate and long-term results in 42 patients. Ann Intern Med 1987;107:560-565.
4. Pengo V, Lensing AW, Prins MH, Marchiori A, Davidson BL, Tiozzo F, et al. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med 2004;350:2257-2264.
5. Pengo V, Prandoni P. From acute pulmonary embolism to chronic thromboembolic pulmonary hypertension. Ital Heart J 2005;5:830-833.
6. Dalen JE, Banas JS Jr, Brooks HL, Evans GI, Paraskos JA, Dexter L. Resolution rate of acute pulmonary embolism in man: an angiographic study. N Engl J Med 1969;280:1194-1199.
7. Tow DE, Wagner HN Jr. Recovery from pulmonary arterial blood flow in patients with pulmonary embolism. N Engl J Med 1967;1053-1059.
8. Fedullo PF, Rubin LJ, Kerr KM, Auger WR, Channick RN. The natural history of acute and chronic thromboembolic disease: the search for the missing link. Eur Respir J 2000;15:435-437.
9. Fedullo PF, Auger WR, Channick RN, Kerr KM, Rubin LJ. Chronic thromboembolic pulmonary hypertension. Clin Chest Med 2001;22:561-581.
10. Wolf M, Boyer-Neumann C, Parent F, Eschwege V, Jaillet H, Meyer D, et al. Thrombotic risk factors for pulmonary hypertension. Eur Respir J 2000;15:395-399.
11. Moser KM, Auger WR, Fedullo PF, et al. Chronic thromboembolic pulmonary hypertension: clinical picture and surgical treatment. Eur Respir J 1992;5:334-342.
12. Auger WR, Kerr KM, Kim NH, Ben-Yehuda O, Knowltown KU, Fedullo PF. Chronic thromboembolic pulmonary hypertension. Cardiol Clin 2004;22:453-466.
13. Moser KM, Bloor CM. Pulmonary vascular lesions occurring in patients with chronic major thromboembolic pulmonary hypertension. Chest 1993;103:685-692.
14. Herve P, Humbert M, Sitbon O, et al. Pathobiology of pulmonary hypertension. The role of platelets and thrombosis. Clin Chest Med 2001;22:451-458.
15. Dartevelle P, Fadel E, Mussot S, Chapelier A, Herve P, de Perrot M, et al. Chronic thromboembolic pulmonary hypertension. Eur Respir J 2004;23:637-648.
16. Fedullo PF, Auger WR, Kerr KM, Rubin LJ. Chronic thromboembolic pulmonary hypertension. N Engl J Med 2001;345:1465-1472.
17. Reidel M, Stanek V, Widimsky J, Prerovsky I. Longterm follow up of patients with chronic pulmonary thromboembolism. Late prognosis and evolution of hemodynamic and respiratory data. Chest 1982;81:151-158.
18. Fedullo PF, Auger WR, Kerr KM, Kim NH. Chronic thromboembolic pulmonary hypertension. Semin Resp Crit Care Med 2003;24:273-285.
19. Auger WR, Moser KM. Pulmonary flow murmurs: a distinctive physical sign found in chronic pulmonary thromboembolic disease. Clin Res 1989;37:145A.
20. Morris TA, Auger WR, Ysrael MZ, Olson LK, Channick RN, Fedullo PF, et al. Parenchymal scarring is associated with restrictive spirometric defects in patients with chronic thromboembolic pulmonary hypertension. Chest 1996;110:399-403.
21. Kapitan KS, Buchbinder M, Wagner PD, Moser KM. Mechanisms of hypoxemia in chronic thromboembolic pulmonary hypertension. Am Rev Respir Dis 1989;139:1149-1154.
22. Woodruff WW III, Hoeck BE, Chitwood WR Jr, Lyerly HK, Sabiston DC Jr, Chen JT. Radiographic findings in pulmonary hypertension from unresolved embolism. AJR Am J Roentgenol 1985;144:681-686.
23. Menzel T, Wagner S, Kramm T, Mohr-Kahaly S, Mayer E, Braeuninger S, et al. Pathophysiology of impaired right and left ventricular function in chronic thromboembolic pulmonary hypertension: changes after pulmonary thromboendarterectomy. Chest 2000;118:897-903.
24. Rich S, Pietra GG, Kieras K, Hart K, Brundage BH. Primary pulmonary hypertension: radiographic and scintigraphic patterns of histologic subtypes. Ann Intern Med 1986;105:499-502.
25. Ryan KL, Fedullo PF, Davis GB, Vasquez TE, Moser KM. Perfusion scan findings understate the severity of angiographic and hemodynamic compromise in chronic thromboembolic pulmonary hypertension. Chest 1988;93:1180-1185.
26. Palevski HI, Cone L, Alavi A. A case of false-positive high probability ventilation-perfusion lung scan due to tuberculous adenopathy with a discussion of other causes of false-positive high probability ventilation-perfusion lung scans. J Nucl Med 1991;32:512-517.
27. King MA, Ysreal M, Bergin CJ. Chronic thromboembolic pulmonary hypertension: CT findings. AJR Am J Roentgenol 1998;170:955-960.
28. Moser KM, Fedullo PF, Finkbeiner WE, Golden J. Do patients with primary pulmonary hypertension develop extensive central thrombi? Circulation 1995;91:741-745.
29. Pitton MB, Dubeer C, Mayer E, Thelen M. Hemodynamic effects of non-ionic contrast bolus injection and oxygen inhalation during pulmonary angiography in patients with chronic thromboembolic pulmonary hypertension. Circulation 1996;94:2485-2491.
30. Auger WR, Fedullo PF, Moser KM, Buchbinder M, Peterson KL. Chronic major-vessel thromboembolic pulmonary hypertension: appearance at angiography. Radiology 1992;182:393-398.
31. Sompradeekul S, Fedullo PF, Kerr KM, Channick RN, Auger WR. The role of pulmonary angioscopy in the preoperative assessment of patients with chronic thromboembolic pulmonary hypertension (CTPH). Am J Respir Crit Care Med 1999;159:A456.
32. Humbert M, Sitbon O, Simmonneau G. Treatment of pulmonary arterial hypertension. N Engl J Med 2004;351:1425-1436.
33. Pulido T. ¿Qué es lo nuevo en el tratamiento de la hipertensión arterial pulmonar? Arch Cardiol Mex 2003;Suppl 1:S121-S124.
34. Porres M, Porres M. Progresos en el tratamiento farmacológico de la hipertensión arterial pulmonar. Med Int Mex 2004;20:208-220.
35. Nagaya N, Shimizu Y, Satoh T, Oya H, Uematsu M, Kyotani S, et al. Oral beraprost sodium improves exercise capacity and ventilatory efficiency in patients with primary or thromboembolic pulmonary hypertension. Heart 2002;87:340-345.
36. Ono F, Nagaya N, Okumura H, Shimitzu Y, Kyotani S, Nakanishi N, et al. Effect of orally active prostacyclin analogue on survival in patients with chronic thromboembolic pulmonary hypertension without major-vessel obstruction. Chest 2003;123:1583-1588.
37. Nagaya N, Sasaki N, Ando M, Ogino H, Sakamaki F, Kyotani S, et al. Prostacyclin therapy before pulmonary thromboendarterectomy in patients with chronic thromboembolic pulmonary hypertension. Chest 2003;123:338-343.
38. Kerr KM, Rubin LJ. Epoprostenol therapy as a bridge to pulmonary thromboendarterectomy for chronic thromboembolic pulmonary hypertension. Chest 2003;123:319-320.
39. Bresser P, Fedullo PF, Auger WR, Channick RN, Robbins IM, Kerr KM, et al. Continuous intravenous epoprostenol for chronic thromboembolic pulmonary hypertension. Eur Respir J 2004;23:595-600.
40. Kramm T, Eberle B, Krummenauer F, Guth S, Oelert H, Mayer E. Inhaled iloprost in patients with chronic thormboembolic pulmonary hypertension: effects before and after pulmonary thromboendarterectomy. Ann Thorac Surg 2003;76:711-718.
41. Ghofrani HA, Schermuly RT, Rose F, Wiedermann R, Kohstall MG, Olschewski H et al. Sildenafil for long-term treatment of nonoperable chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med 2003;167:1139-1141.
42. Pulido T, Porres M, Miranda E, Bautista E, Santos E, Rojas G, et al. Dipyridamol as adjuvant therapy in patients with pulmonary arterial hypertension (PAH). Eur Respir J 2005;26:S562.
43. Humbert M, Barst RJ, Robbins IM, Channick R, Galie N, Boonstra A, et al. Combination with bosentan with epoprostenol in patients with pulmonary arterial hypertension: BREATHE-2 study. Eur Respir J 2004;24:353-359.
44. Bonderman D, Nowotny R, Skoro-Sajer N, Jakowitsch J, Adlbrecht C, Klepetko W, et al. Bosentan therapy for inoperable chronic thromboembolic pulmonary hypertension. Chest 2005;128:2599-2603.
45. Hoeper M, Kramm T, Wilkens H, Schulze C, Schafers HJ, Welte T, et al. Bosentan therapy for inoperable chronic thromboembolic pulmonary hypertension. Chest 2005;128:2363-2367.